Work

Prolonged Survival and Improved Response Rates With ARRY-520 In Relapsed/Refractory Multiple Myeloma (RRMM) Patients With Low α-1 Acid Glycoprotein (AAG) Levels: Results From a Phase 2 Study

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.285.285

Authors: Sagar Lonial, Jatin J. Shah, Jeffrey Zonder, William I. Bensinger, Adam D. Cohen, Jonathan L. Kaufman, Ajay K. Nooka, Donna M. Weber, Brandi Hilder, Selena A Rush, Ann Ptaszynski, Duncan Walker, Robert Z. Orlowski

Institutions: Emory University, Winship Cancer Institute, The University of Texas MD Anderson Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Fred Hutch Cancer Center, Fox Chase Cancer Center, Array BioPharma (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W8713393

FWCI: 4.784

Cites:

Cited by: 28

Related to: 10